Medicine
Regranex Gel 0.01% 0.01% gel
Regranex Gel 0.01% 0.01% gel is a prescription medicine containing Becaplermin for topical use, marketed by LRM Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2° - 8°C (36° - 46°F). Do not freeze.
Key facts
- Active ingredient (INN)
- Becaplermin
- Brand
- Regranex Gel 0.01%
- Strength
- 0.01%
- Dosage form
- Gel
- Route
- Topical
- Packs
- 15 g
- Marketing authorisation holder
- LRM Therapeutics
- Manufacturer
- LRM Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2° - 8°C (36° - 46°F). Do not freeze.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A01AD08 Becaplermin
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 June 2025
- Identifiers
- RxCUI 213197, 308579DailyMed set ID 377b3021-13d7-96d5-e063-6394a90a8ca3NDC 85822-734Application BLA103691
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 15 g in 1 tube | 85822-734-15 | LRM Therapeutics | 30 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Becaplermin is a human platelet-derived growth factor indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply, among other approved uses. MedsAcross supplies Becaplermin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BecaplerminFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Regranex Gel 0.01% prescribing information (LRM Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Regranex Gel 0.01% 0.01% gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.